Log In
Print this Print this

KOS-1584 (formerly R1645)

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionSecond-generation epothilone polyketide
Molecular Target Tubulin
Mechanism of ActionMicrotubule stabilization
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationNon-small cell lung cancer (NSCLC)
Indication DetailsTreat non-small cell lung cancer (NSCLC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today